Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BEAM THERAPEUTICS INC(BEAM) | 2,266,934 | 2,266,934 | 0 | 53,114 | 55,540 | 61.51% | +2,426 |
| LYELL IMMUNOPHARMA INC(LYEL) | 20,162,332 | 20,162,332 | 0 | 29,235 | 27,824 | 30.81% | -1,411 |
| PRIME MEDICINE INC(PRME) | 1,792,210 | 1,792,210 | 0 | 9,212 | 6,936 | 7.68% | -2,276 |